文献速递糖尿病

糖尿病诊疗标准2026:血糖治疗的药物治疗路径

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.
PubMed 文献 · Diabetes Care · 2026-01-01

美国糖尿病协会(ADA)专业实践委员会更新发布《糖尿病诊疗标准2026》第9章,聚焦血糖治疗的药物治疗方案。本章提供当前临床实践推荐、一般治疗目标与指南框架,并沿用ADA证据分级体系,供临床评估诊疗质量使用。

要点

  • ADA标准每年更新,第9章专门阐述血糖治疗的药物选择路径。
  • 推荐条款基于ADA证据分级系统,覆盖一般治疗目标与质量评估工具。
  • 本章面向多学科团队,提供当前血糖药物管理的实践框架。

核心结论

  • ADA《糖尿病诊疗标准2026》第9章提供血糖治疗的当前临床实践推荐、一般治疗目标与指南框架。

研究设计与样本

  • 由ADA糖尿病专业实践委员会(跨学科专家委员会)负责每年或按需更频繁地更新。

临床怎么用

  • 临床可依据本章推荐条款制定血糖药物治疗方案,并使用ADA工具评估诊疗质量。

局限性

  • 原文未涉及具体药物推荐剂量、阈值或证据等级细节,需参阅原文相应章节获取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026. Diabetes Care. 2026. PMID: 41358900. doi:10.2337/dc26-S009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。